Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Mudcat who wrote (24014)	8/5/1998 6:00:00 PM
From: tonyt	Read Replies (1) \| Respond to of 32384

><you might also point out to "mudcat" that Cheryl Galt is a real person with a real name> Mudcat, don't bite at the shadow's bait. You were right, he was wrong and his only 'defense' is to try to discredit anyone that doesn't post their 'real name'. The shadow also knows that 'real names' mean 'zip' It adds nothing to the credibility of the post. Yes, hindsight is indeed 20/20, but it is also indisputable. The Ligand bulls were wrong. They touted this stock as a 'slam dunk' and predicted easy and early returns. Almost none of the bulls, (real names, or handles) discussed the risks or ways to reduce risk. When someone proposed that one way was to sell 1/2 when LGND pop'd there were many bulls that jumped in to say that it was 'naysaying' and that it was trading like this that held LGND below $20. Yes indeed. Hindsight is 20/20.